Namely, Aynali et al. showed the existence of an increased risk of laryngeal cancer in the population of smokers who had the SOD2 Val16Val genotype, but not in smokers with polymorphic variants of GPX1 [66]. This evidence concerns the gene SOD2 and laryngeal carcinoma.